These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28822967)

  • 1. Temporal dynamics of cardiac hypertrophic growth in response to pressure overload.
    Wang Y; Zhang Y; Ding G; May HI; Xu J; Gillette TG; Wang H; Wang ZV
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1119-H1129. PubMed ID: 28822967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure overload induces early morphological changes in the heart.
    Souders CA; Borg TK; Banerjee I; Baudino TA
    Am J Pathol; 2012 Oct; 181(4):1226-35. PubMed ID: 22954422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
    Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
    J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
    Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
    Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.
    Sakata Y; Hoit BD; Liggett SB; Walsh RA; Dorn GW
    Circulation; 1998 Apr; 97(15):1488-95. PubMed ID: 9576430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
    Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophy.
    Chang YW; Chang YT; Wang Q; Lin JJ; Chen YJ; Chen CC
    Mol Cell Proteomics; 2013 Nov; 12(11):3094-107. PubMed ID: 23882026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of c-fos mRNA expression by pure pressure overload in cultured cardiac myocytes.
    Sakai H; Urasawa K; Oyama N; Kaneta S; Saito T; Kitabatake A; Tsutsui H
    Int Heart J; 2007 May; 48(3):359-67. PubMed ID: 17592200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.
    Gold JI; Gao E; Shang X; Premont RT; Koch WJ
    Circ Res; 2012 Sep; 111(8):1048-53. PubMed ID: 22859683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pioglitazone inhibits cardiac hypertrophy of rats in vitro and in vivo].
    Ye P; Zhang C; Wu SM; Liu YX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):35-9. PubMed ID: 21166160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preserved heart function after left ventricular pressure overload in adult mice subjected to neonatal cardiac hypoplasia.
    Heinecke K; Heuser A; Blaschke F; Jux C; Thierfelder L; Drenckhahn JD
    J Dev Orig Health Dis; 2018 Feb; 9(1):112-124. PubMed ID: 28737122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
    Kuhn C; Frank D; Dierck F; Oehl U; Krebs J; Will R; Lehmann LH; Backs J; Katus HA; Frey N
    Basic Res Cardiol; 2012 May; 107(3):262. PubMed ID: 22421737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.